Skip to main content

Leading startups benefit from BaselArea.swiss

| News

Leading startups benefit from BaselArea.swiss

05.09.2019

The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in the biotech sector, while almost all the Basel companies named have benefited directly or indirectly from BaselArea.swiss.

time for startup (img: Tashatuvango/shutterstock)

Seven companies from the canton of Basel-Stadt and two from the canton of Basel-Landschaft qualified for the Top 100 of Swiss startups. Now, Venturelab has published its latest ranking. Five biotech startups made it into the top 20 – and two of them are from Basel.

Polyneuron Pharmaceuticals AG (14th place) received support from the healthcare accelerator BaseLaunch, which is operated by BaselArea.swiss. The location promotion organization also directly provided services to Cellestia Biotech AG (19th place). With T3 Pharmaceuticals (24th place) and Anaveon AG (37th place) from Bottmingen BL, two other Basel companies supported by BaseLaunch made it into the top 40.

In this year’s top 40 Swiss startups are MaxWell Biosystems (33rd place) and Artidis (36th place). Alongside medtech company Resistell (34th place) from Muttenz BL, they too benefited from BaselArea.swiss. The same goes for the micro- and nanotechnology company Qnami (64th place) from Basel. Internet and mobile company MyCamper (87th place) rounds off the Basel region’s companies in the top 100.

The list is topped by four companies in the electronics/mechanics and medtech sectors. In first place is Lausanne drone provider Flyability, followed by medtech company Lunaphore, which also hails from Lausanne. Two German-Swiss companies are in places 3 and 4 – the Zurich medtech company Ava and flight devices provider Wingtra from Zug. The best biotech company in the ranking is Cutiss AG from Zurich in 6th place.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.